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Conduits and endoconduits, percutaneous access
Brian G. Peterson, MD, St. Louis, MoDespite technologic improvements in endovascular de-
vices used to treat thoracic aortic diseases and rapidly
growing physician familiarity with the use of these devices,
access-related complications remain one of the most com-
mon sources of morbidity and mortality during thoracic
endovascular aortic repair (TEVAR). Standard, remote ar-
terial access through a femoral artery approach is often not
possible during TEVAR when these patients have small-
caliber or diseased iliofemoral vessels. Various methods
have been developed to combat these issues and include the
use of open iliac conduits or direct aortic access through
retroperitoneal exposures, or more recently, endoconduits
that enable treatment of remote disease processes in the
thoracic aorta through a femoral approach. One of the
goals of this article is to discuss the options available for
addressing these access-related limitations of TEVAR—
conduits and endoconduits—and provide physicians with
descriptions of techniques that can become part of their
armamentarium in treating these difficult patients.
The standard approach to the femoral arteries during
TEVAR is through open groin exposure. This is largely
because TEVAR requires delivery sheath sizes of 18F to
24F. An effort has been made to make these procedures
even less invasive and to avoid the complications inherent in
surgical exposure of the femoral arteries. As endovascular
specialists have become more familiar with percutaneous
closure devices routinely used in interventions that use
smaller sheaths, the use of a totally percutaneous approach
has been adopted by many physicians who perform
TEVAR. This article will discuss the “Preclose” technique
used in percutaneous endovascular aortic repair and review
the current literature related to this approach.
CONDUITS AND ENDOCONDUITS
Besides having an adequate proximal or distal seal zone,
one of the major determinants of whether a patient is a
candidate for TEVAR is the status of the iliofemoral arterial
system. Small-caliber vessels or the presence of occlusive
disease often prevents femoral access. This, combined with
the need for large-diameter delivery sheaths, makes remote
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60Sfemoral access difficult in a large number of patients who
would otherwise be candidates for TEVAR.
Industry-sponsored TEVAR trials and an international
survey of physicians performing TEVAR have demon-
strated that iliac artery limitations lead to the use of con-
duits in 9% to 21% of patients undergoing TEVAR.1-4 In
one of the industry-sponsored trials, despite technical suc-
cess in treating the thoracic aortic aneurysm, vascular com-
plications related to the access occurred in 21% of the
patients.3 These access problems account for a large por-
tion of the morbidity associated with TEVAR. Iliac artery
disruption during TEVAR can lead to devastating out-
comes; namely, uncontrolled hemorrhage and even death.
Several key access-related issues need to be considered
when deciding whether a patient is a candidate for TEVAR.
The first starts with predicting which patients could poten-
tially have access limitations. The best way to determine this
is with adequate preoperative imaging. Fine-cut computed
tomography (CT) scans should be used in all patients being
considered for TEVAR. This imaging is not limited to
focusing on the thoracic aortic pathology alone, but should
include complete imaging through the femoral heads to
assess the distal vasculature as well. Most imaging programs
contain measurement tools to accurately assess the size of
the iliac vessels. Small-caliber vessels, those with a diameter
7 mm, often prevent passage of the delivery sheaths
needed for TEVAR. These vessels, especially in younger
patients, can be quite elastic, however, and they may be able
to accommodate sheaths on the lower end of the diameter
spectrum (ie, 18F to 20F).
Tortuosity and prior iliac stenting can also be a limiting
factor in TEVAR, but most important is the presence of
calcification. Calcification, especially in older patients, of-
ten signifies stiff, less elastic vessels that may be more prone
to rupture with sheath trauma. Small-caliber vessels with
areas of stenosis and calcification require adjunctive tech-
niques for successful completion of TEVAR. This scenario
highlights the second preoperative planning key to limiting
access-related problems during TEVAR—prevention. Pre-
vention refers to the liberal use of conduits when faced with
unfavorable anatomy. The dictum holds true that if you
contemplate using a conduit, you should do just that—use
a conduit.
The most common of the various types of conduit is the
open surgical conduit through a retroperitoneal exposure
of the common iliac artery or distal aorta. Some of the key
technical points of using iliac arterial conduits in the setting
of TEVAR are addressed in a 10-year experience published
by Criado.5 A standard retroperitoneal exposure allows for
control of the common iliac artery (Fig 1) or distal aorta.
Next, a 10-mm polyester graft is sewn to the artery in an
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facilitate unilateral access because this graft can accommo-
date both the large delivery sheath needed for TEVAR and
a smaller sheath used for a diagnostic angiogram catheter
(Fig 3). As seen in Fig 3, the end of the conduit is clamped
and the sheaths are inserted through the side of the con-
duit. This avoids unnecessary blood loss if sheath exchanges
are needed and if they are performed through the end of the
conduit. The tip of the delivery sheath should be advanced
through the newly created anastomosis so that disruption
of the anastomosis does not occur with multiple exchanges.
A surgical clip can be used to readily identify the anastomo-
sis fluoroscopically. Others have suggested reinforcing the
anastomosis with a cuff and using manual stabilization
when advancing the sheath through the fresh anastomosis.6
Upon completion of the TEVAR, the sheaths are re-
moved and the conduit can be oversewn, leaving a small
cuff of graft on the native artery (Fig 4). Alternatively, if the
Fig 1. Retroperitoneal exposure demonstrates a longitudinal ar-
teriotomy in the common iliac artery for placement of a conduit.
Fig 2. A 10-mm polyester graft has been anastomosed to the
common iliac artery in an end-to-side fashion.patient has a history of symptomatic iliac occlusive disease,the conduit can be converted into an iliofemoral bypass by
performing an anastomosis to the femoral artery. Either
way, prosthetic is left behind, raising the concern for po-
tential graft infection.
In an effort to reduce this risk, Carpenter advocated
direct iliac or aortic access without the use of prosthetic.7
This involves an arterial puncture in the middle of a purse-
string suture placed directly on the artery. Upon comple-
tion, the sheath is removed and the adventitial suture is
tied, closing the arteriotomy. Both of these approaches
address the iliac artery limitations, but they can also add to
the morbidity of TEVAR because they both require retro-
peritoneal exposures. In fact, Lee et al8 demonstrated that
compared with a femoral approach, this retroperitoneal
approach leads to a 2.6-fold greater blood loss, 1.5-day
Fig 3. A conduit used during thoracic endovascular aortic repair.
Notice that the end of the conduit is controlled with a clamp and
that a sidewall puncture permits simultaneous passage of a 5F
sheath for diagnostic purposes and a 24F sheath for device delivery.
Fig 4. A transected and oversewn conduit cuff; alternatively, the
conduit can be used as an iliofemoral bypass graft in the setting of
symptomatic iliac occlusive disease.longer length of stay, and an 82% longer procedure time.
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aortic access help prevent potentially fatal iliac complica-
tions and overcome not only problems associated with
diseased vessels but also vessel tortuosity.
Retroperitoneal exposures can be avoided and femoral
access is possible using a variety of previously described
endovascular techniques. The simplest of these is balloon
angioplasty,9 but retrograde endarterectomy or the se-
quential passage of dilators of increasing size are also op-
tions. Care must be taken to avoid overly aggressive angio-
plasty because vessel rupture is certainly possible in heavily
calcified vessels.
A technique that Dr Matsumura and I first described10
attempts to address the issue of iliac rupture in a more
controlled fashion and involves the use of an endoconduit.
A covered stent is deployed across the diseased iliac seg-
ment from a femoral approach, either percutaneously or
through open femoral exposure. We have used two differ-
ent devices in an off-label fashion to serve as the endocon-
duit. The first is a contralateral iliac limb endoprosthesis
(W.L. Gore & Associates, Flagstaff, Ariz) designed for use
in endovascular abdominal aortic aneurysm repair. This
device has a 16-mm proximal end that is deployed in the
common iliac artery and a 12-mm distal end that is ex-
tended into the proximal common femoral artery or the
distal external iliac artery just under the inguinal ligament.
Device oversizing and iliac tortuosity can be a problem with
this device; in select cases, a commercially available Viabahn
covered stent (W.L. Gore & Associates) has been used in
favor over the iliac limb endoprosthesis. This device has
several advantages, including a lower profile, less oversiz-
ing, and more flexibility, but both devices have been used
with success.
After deployment, the endoconduit is aggressively
balloon-angioplastied, creating a proximal and distal seal, as
well as a controlled rupture of the diseased iliac segment
(Fig 5). Angioplasty with a 10-mm balloon allows for
passage of sheaths up to 22F, and a 12-mm balloon accom-
modates a 24F sheath (Fig 6). Ideally, the rupture occurs in
the midportion of the external iliac artery and is done in a
controlled manner, having first obtained a proximal and
distal seal. If the narrowest or most diseased portion of the
iliac artery is adjacent to a patent hypogastric artery, embo-
lization of the hypogastric artery before deployment of the
endoconduit may prevent retrograde hemorrhage analo-
gous to a type II endoleak, but this has not been necessary
in our experience.
Other potential downfalls of endoconduits include
complications of decreased pelvic perfusion, namely, but-
tock claudication or paraplegia. Fortunately, we have not
seen paraplegia in this setting, and most buttock claudica-
tion improves with cilostazol. We have learned from our
experience to extend the endoconduit at least down to the
inguinal ligament and, possibly, into the proximal common
femoral artery. This is to prevent rupture of the intervening
segment of artery between the puncture site and the end of
the endoconduit. On two occasions, rupture in this seg-
ment of artery has required repair with a short interpositiongraft between the end of the endoconduit and the common
femoral artery. Nevertheless, in our growing experience,
endoconduits have made TEVAR possible using femoral
access with few complications, even in the setting of unfa-
Fig 5. Balloon angioplasty within the endoconduit creates a con-
trolled rupture of the iliac artery.
Fig 6. The endoconduit allows for the passage of a large-diameter
delivery sheath.vorable iliac artery anatomy.
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Owing in part to the large sheath requirements of
TEVAR, standard access has involved open femoral artery
exposure when conduits are not used. In an effort to avoid
the complications of a groin incision, namely, wound infec-
tion, hematoma, lymphocele, and paresthesias, many endo-
vascular specialists have adopted a totally percutaneous
approach to TEVAR. Percutaneous TEVAR uses the “Pre-
close” technique to close common femoral artery puncture
sites, which most series have shown is safe and effective.
Successful percutaneous access begins with adequate
imaging and patient selection. As mentioned, preoperative
CT scans should extend down through the femoral heads.
The location of the femoral bifurcation in relation to the
femoral heads should be noted, and in the rare instance of
a high femoral bifurcation at the level of the inguinal
ligament, percutaneous TEVAR should not be attempted.
Extensive anterior wall calcification is also considered a
contraindication to the percutaneous approach. Although
most physicians avoid the percutaneous approach in obese
patients, these patients may actually benefit the most from
percutaneous TEVAR given the higher likelihood of
wound complications in this group. A recently published
series of 900 percutaneous approaches during endovas-
cular aortic repair failed to demonstrate a higher failure rate
in obese patients.11
The most important step in performing percutaneous
access safely is ensuring an anterior wall common femoral
artery puncture. Ultrasound guidance using an echogenic-
tipped micropuncture needle is probably the best way to
facilitate common femoral artery puncture. After the mi-
cropuncture sheath is placed, a femoral angiogram in an
ipsilateral oblique projection with medial deflection of
the sheath should be performed in all cases to accurately
determine the puncture site. If access is not clearly in
the common femoral artery, defined angiographically as
the artery distal to the epigastric branch and proximal
to the femoral bifurcation, another common femoral
puncture should be attempted. An external iliac artery
puncture during a percutaneous approach to TEVAR can
lead to devastating complications for several reasons. The
location of the puncture superior to the femoral head does
not allow for adequate hemostasis with manual compres-
sion. Also, the knots of the suture-mediated closure device
can get hung up on the inguinal ligament without cinching
down on the artery, leading to retroperitoneal hemorrhage.
If unrecognized, patients can become dramatically unstable
secondary to rapid exsanguination. Likewise, punctures of
the superficial or deep femoral arteries can be difficult to
control with manual compression, and these smaller-caliber
vessels are more prone to thrombosis. It cannot be under-
stated that every effort should be made to confirm common
femoral artery access before proceeding with percutaneous
TEVAR.
The “Preclose” technique has been described using
two different suture-mediated closure devices in an off-
label fashion: the Prostar XL and the Perclose ProGlide(both from Abbott Vascular, Abbott Park, Ill).12,13 The
techniques are similar. After common femoral artery access
is obtained, the closure devices are deployed before upsiz-
ing to the large-diameter delivery sheath needed for
TEVAR. The sutures are tied down after completion of
TEVAR and removal of the delivery sheaths. Suture tying
should be performed with a wire remaining in place to allow
for insertion of an occlusion balloon should hemostasis not
be obtained. If the closure does not seem adequate, closure
can be attempted with deployment of another device, or
repair can be performed by open femoral artery exposure.
The percutaneous approach to TEVAR has been shown
to be safe and effective, with minimal short- and long-term
complications. Rates of technical success using percutane-
ous access in large series have ranged from 93% to
96%.11,14,15 In the largest series to date, predictors of
conversion to open femoral repair are femoral artery calci-
fication and operator experience.11 Late complications of
the percutaneous approach include pseudoaneurysms,
thrombosis, and dissection, but these have been seen in
4% of patients.11,15 Apart from avoiding the complica-
tions seen with open femoral artery exposure, advantages of
the percutaneous approach include shorter length of stay
and time to ambulation.14,16 Experienced endovascular
specialists can safely perform percutaneous TEVAR with a
low incidence of early or late access-related complications
in many patients.
CONCLUSIONS
Despite advances in endograft delivery system design,
unfavorable iliac artery anatomy remains one of the most
common difficulties of using TEVAR to treat patients with
thoracic aortic problems. Various strategies can be used to
overcome these obstacles, each possessing advantages and
disadvantages with which endovascular specialists must be
familiar. Percutaneous TEVAR can be performed safely and
effectively in many patients, and the use of endoconduits
can further increase the number of patients who can be
treated through femoral artery access. Nevertheless, it is
imperative that physicians capable of open vascular surgery
techniques be involved in the treatment of these patients
undergoing TEVAR.
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